[HTML][HTML] Immunotherapy: a challenge of breast cancer treatment

M García-Aranda, M Redondo - Cancers, 2019 - mdpi.com
Breast cancer is the most commonly diagnosed cancer in women and is a leading cause of
cancer death in women worldwide. Despite the significant benefit of the use of conventional …

[HTML][HTML] A review of biosensors for detecting tumor markers in breast cancer

R Hong, H Sun, D Li, W Yang, K Fan, C Liu, L Dong… - Life, 2022 - mdpi.com
Breast cancer has the highest cancer incidence rate in women. Early screening of breast
cancer can effectively improve the treatment effect of patients. However, the main diagnostic …

[HTML][HTML] Biomarkers in breast cancer: an old story with a new end

L Neves Rebello Alves, D Dummer Meira… - Genes, 2023 - mdpi.com
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease
and the leading cause of cancer mortality in women. Advances in molecular technologies …

[HTML][HTML] Pharmacogenetics of drug metabolism: the role of gene polymorphism in the regulation of doxorubicin safety and efficacy

AA Bagdasaryan, VN Chubarev, EA Smolyarchuk… - Cancers, 2022 - mdpi.com
Simple Summary The effectiveness and safety of the anti-cancer agent doxorubicin
(anthracycline group medicine) depend on the metabolism and retention of the drug in the …

[HTML][HTML] Pancreatic cancer and therapy: role and regulation of cancer stem cells

S Barman, I Fatima, AB Singh, P Dhawan - International journal of …, 2021 - mdpi.com
Despite significant improvements in clinical management, pancreatic cancer (PC) remains
one of the deadliest cancer types, as it is prone to late detection with extreme metastatic …

Curcumin complexed with graphene derivative for breast cancer therapy

D De, CK Das, D Mandal, M Mandal… - ACS Applied Bio …, 2020 - ACS Publications
In recent years, graphene-based materials complexed with drugs have been developed for
application in cancer therapy, aimed at gaining synergistic effect. Here, we have prepared …

[HTML][HTML] Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy

M Nunziato, F Di Maggio, M Pensabene… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is the most common neoplasia in females worldwide, about 10% being
hereditary/familial and due to DNA variants in cancer-predisposing genes, such as the …

Prognostic value estimation of BRIP1 in breast cancer by exploiting transcriptomics data through bioinformatics approaches

U Khan, MS Khan - Bioinformatics and Biology Insights, 2021 - journals.sagepub.com
BRIP1 (Breast Cancer 1 Interacting Helicase 1) is a tumor suppressor gene that has vital
function in preserving the genetic stability by repairing DNA damage though have significant …

[HTML][HTML] The role of photodynamic therapy in breast cancer–A review of in vitro research

M Czarnecka-Czapczyńska, D Aebisher, P Oleś… - Biomedicine & …, 2021 - Elsevier
Breast cancer is the most common cancer affecting women and the incidence of occurrence
is increasing. Currently, there are many methods of detecting and treating breast cancer …

[HTML][HTML] New, fast and cheap prediction tests for BRCA1 gene mutations identification in clinical samples

A Gajda-Walczak, A Potęga, A Kowalczyk, S Sek… - Scientific Reports, 2023 - nature.com
Despite significant progress in cancer therapy, cancer is still the second cause of mortality in
the world. The necessity to make quick therapeutic decisions forces the development of …